$116.982,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

In this issue of Surgical Pathology Clinics, guest editor Dr. Hannah Yong Wen brings her considerable expertise to the topic of Breast Pathology. Top experts help readers enhance their knowledge of breast tumors with the latest information on molecular testing; ER, PR, and HER2 testing; and fibroepithelial lesions and spindle cell lesions, as well as digital and AI pathology.

  • Contains 12 relevant, practice-oriented topics including special subtypes of triple negative breast cancer; prognostic and predictive assays in invasive breast carcinoma beyond ER, PR and HER2; molecular testing in breast cancer; immunohistochemistry in diagnostic breast pathology; and more
  • Provides in-depth clinical reviews on breast pathology, offering actionable insights for clinical practice
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. Spindle Cell Lesions - p. 639 9. Neuroendocrine Neoplasms of the Breast: Evolving Concepts and Reappraisal of Classification - p. 651 10. Special Subtypes of Triple Negative Breast Carcinoma - p. 665 11. Fibroepithelial Lesions: An Update for Daily Practice (Part-I) - p. 675 12. Fibroepithelial Lesions: An Update for Daily Practice (Part-II) - p. 701 13. High-Risk Breast Lesions on Core Biopsy: Rates of Upgrade and Management Recommendations - p. 707 14. Tumor Infiltrating Lymphocytes in Breast Cancer: Why Is It Useful to Know? - p. 725 15. Hormone Receptor and HER2 Testing in Breast Cancer: Latest Questions Answered - p. 735 16. Prognostic and Predictive Assays in Invasive Breast Carcinoma Beyond Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 - p. 751 17. Contemporary Issues in Immunohistochemistry Utilization in Breast Pathology - p. 759 18. Molecular Testing in Breast Cancer: A Guide for Surgical Pathologists - p. 779 19. Digital Pathology and Artificial Intelligence in Breast Pathology - p. 791

Descripcion
Descripción

In this issue of Surgical Pathology Clinics, guest editor Dr. Hannah Yong Wen brings her considerable expertise to the topic of Breast Pathology. Top experts help readers enhance their knowledge of breast tumors with the latest information on molecular testing; ER, PR, and HER2 testing; and fibroepithelial lesions and spindle cell lesions, as well as digital and AI pathology.

  • Contains 12 relevant, practice-oriented topics including special subtypes of triple negative breast cancer; prognostic and predictive assays in invasive breast carcinoma beyond ER, PR and HER2; molecular testing in breast cancer; immunohistochemistry in diagnostic breast pathology; and more
  • Provides in-depth clinical reviews on breast pathology, offering actionable insights for clinical practice
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. Spindle Cell Lesions - p. 639 9. Neuroendocrine Neoplasms of the Breast: Evolving Concepts and Reappraisal of Classification - p. 651 10. Special Subtypes of Triple Negative Breast Carcinoma - p. 665 11. Fibroepithelial Lesions: An Update for Daily Practice (Part-I) - p. 675 12. Fibroepithelial Lesions: An Update for Daily Practice (Part-II) - p. 701 13. High-Risk Breast Lesions on Core Biopsy: Rates of Upgrade and Management Recommendations - p. 707 14. Tumor Infiltrating Lymphocytes in Breast Cancer: Why Is It Useful to Know? - p. 725 15. Hormone Receptor and HER2 Testing in Breast Cancer: Latest Questions Answered - p. 735 16. Prognostic and Predictive Assays in Invasive Breast Carcinoma Beyond Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 - p. 751 17. Contemporary Issues in Immunohistochemistry Utilization in Breast Pathology - p. 759 18. Molecular Testing in Breast Cancer: A Guide for Surgical Pathologists - p. 779 19. Digital Pathology and Artificial Intelligence in Breast Pathology - p. 791

Indice
Autores
Muestra
Ficha Técnica